WeLeader Biomedical Co

WeLeader Biomedical Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of WeLeader Biomedical Co (7713.TWO) as of Oct 9, 2026 is 261.13 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 198.30 M TWD — a change of 31.68% (higher).

EBITDA

261.13 MTWD

YoY

31.68%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of WeLeader Biomedical Co is 2025 261.13 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of WeLeader Biomedical Co was 2024 198.30 M TWD. It decreases by 31.68% higher compared to the previous year.

The WeLeader Biomedical Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2020
68.56 M TWD
Jan 1, 2021
133.98 M TWD
Jan 1, 2022
195.31 M TWD
Jan 1, 2023
198.30 M TWD
Jan 1, 2025
261.13 M TWD
The WeLeader Biomedical Co EBITDA history
YEAREBITDAYoY
261.13 MTWD+31.68%
198.30 MTWD+1.53%
195.31 MTWD+45.78%
133.98 MTWD+95.43%
68.56 MTWD—
Access this data via the Eulerpool API
Get Free API Key

WeLeader Biomedical Co Stock analysis

What does WeLeader Biomedical Co do? WeLeader Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about WeLeader Biomedical Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of WeLeader Biomedical Co is 261.13 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of WeLeader Biomedical Co changed from 198.30 M TWD to 261.13 M TWD, representing a 31.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) WeLeader Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s WeLeader Biomedical Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — WeLeader Biomedical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — WeLeader Biomedical Co